“Regulating neuronal excitability: The role of S-palmitoylation in NaV1.7 activity and voltage sensitivity”
Authors: Tang C, Duran P, Calderon-Rivera A, Loya-Lopez S, Gomez K, Perez-Miller S, Khanna R.
All Posts by
Meagan Horan
“Peptide and Peptidomimetic Inhibitors Targeting the Interaction of Collapsin Response Mediator Protein 2 with the N-Type Calcium Channel for Pain Relief.”
Authors: Perez-Miller S, Gomez K, Khanna R.
“Small molecule targeting NaV1.7 via inhibition of CRMP2-Ubc9 interaction reduces pain-related outcomes in a rodent osteoarthritic model.”
Authors: Hestehave S, Allen HN, Gomez K, Duran P, Calderon-Rivera A, Loya-López S, Rodríguez-Palma EJ.
“Uncoupling the CRMP2-CaV2.2 Interaction Reduces Pain-Like Behavior in a Preclinical Joint-Pain Model”
Authors: Allen HN, Hestehave S, Duran P, Nelson TS, Khanna R.
“SUMOylation and DeSUMOylation: Tug of War of Pain Signaling”
Authors: Calderon-Rivera A, Gomez K, Rodríguez-Palma EJ, Khanna R.
“Systemically targeting monocytic myeloid-derived suppressor cells using dendrimers and their cell-level biodistribution kinetics”
Authors: Littrell CA, Takacs GP, Sankara CS, Sherman A, Rubach KA, Garcia JS, Bell CA, Lnu T, Harrison JK, Zhang F.
“CSF1R Ligands Expressed by Murine Gliomas Promote M-MDSCs to Suppress CD8+ T Cells in a NOS-Dependent Manner.”
Authors: Takacs GP, Garcia JS, Hodges CA, Kreiger CJ, Sherman A, Harrison JK.
“Optimal control of combination immunotherapy for a virtual murine cohort in a glioblastoma-immune dynamics model.”
Authors: Anderson HG, Takacs GP, Harrison JK, Rong L, Stepien TL.
“Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer.”
Authors: Sarwar S, Morozov VM, Newcomb MA, Yan B, Brant JO, Opavsky R, Guryanova OA, Ishov AM.
“Decoding the identity of rare tumors.”
Authors: Yuan Q, Kaur P, Guryanova OA.